Dividend King Growth Giant: J&J Faces Lilly Challenge
Johnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
Stay within budget with practical, repeatable habits that reinforce good spending choices and support your financial goals.
22,060 articlesJohnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
The trump memecoin ethics fight dominates crypto policy debates as law enforcement softens opposition and ethics conc...
As SpaceX prepares to debut on the public market, analysts clash over whether the company is fairly valued amid volat...
Rivian priced a 75 million share secondary offering, sending its stock down around 14% and triggering a market-wide p...
Ford is recalling 177,000 vehicles after regulators flagged wiper and drivetrain faults. The recall covers certain Mu...
Vanguard has posted a high-level digital assets role, signaling a deeper push into crypto within its vast wealth busi...
July markets bring attention to enduring brands and steady income. Coca-Cola's blend of dividend discipline, pricing ...
SpaceX going public could shift attention, but Rocket Lab’s ongoing contracts, backlog, and execution milestones keep...
Homeowners may reduce monthly costs by recasting their existing loan balance, avoiding new appraisals or credit check...
Tech insiders are stepping up their open-market purchases in software, chipmakers, and AI platforms, reviving a contr...
Fermi America slumped 11.5% as it unveiled a $375 million convertible note offering and reported a Q1 with zero reven...
A CFO selling NuScale stock can spark questions about the company’s outlook. This guide breaks down what the move mig...